The Prognostic Value of ctDNA and bTMB on Immune Checkpoint Inhibitors in Human Cancer

BACKGROUND: Circulating tumor DNA (ctDNA) levels and blood tumor mutation burden (bTMB) have a significant impact on the prognosis of tumor patients. However, their prognostic role in immune checkpoint inhibitors (ICIs) in cancer patients is still unclear. METHODS: We used the Review Manager softwar...

Descripción completa

Detalles Bibliográficos
Autores principales: Wei, Jiayan, Feng, Jia, Weng, Yiming, Xu, Zexi, Jin, Yao, Wang, Peiwei, Cui, Xue, Ruan, Peng, Luo, Ruijun, Li, Na, Peng, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2021
Materias:
Oncology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517328/
https://www.ncbi.nlm.nih.gov/pubmed/34660274
http://dx.doi.org/10.3389/fonc.2021.706910

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8517328/
https://www.ncbi.nlm.nih.gov/pubmed/34660274
http://dx.doi.org/10.3389/fonc.2021.706910

Ejemplares similares